Asking about Complex Policies
As political issues have increased in complexity, public opinion researchers increasingly ask respondents about sophisticated political topics that may require substantive knowledge and analytic skill
Research
The U.S. Place-Based Policy Supply Chain
Place-based policy in the United States comprises a wide range of government programs that are spread across federal, state, and local agencies and that rely on public, private, and nonprofit organiza
Vanguard: Black Veterans and Civil Rights after World War I
Nearly 400,000 Black men were drafted into the National Army during World War I, where they toiled in segregated units and received little formal training.
Investigator racial diversity and clinical trial participation
We investigate whether increased racial diversity of clinical trial principal investigators could increase the enrollment of Black patients, which currently lags population and disease-burden.
Mean Reversion in Randomized Controlled Trials: Implications for Program Targeting and Heterogeneous Treatment Effects
Eligibility criteria for interventions can induce an Ashenfelter Dip, and subsequent mean-reversion may result in improvement over time even absent the intervention.
Ideological Bias in Estimates of the Impact of Immigration
When studying policy-relevant topics, researchers’ policy preferences may shape the design, execution, analysis, and interpretation of results.
Racial health disparities in the United States
Disparities between Black and White Americans in health care coverage and health outcomes are pervasive in the United States.
Willingness-To-Pay vs Administrative Hurdles: Understanding Barriers to Social Insurance Enrollment in Thailand
Many government social insurance policies have low take-up.
Health Equity in the 2024 U.S. Presidential Election
The next U.S. president will inherit multiple epidemics with inequitably distributed effects. Kamala Harris and Donald Trump are likely to take divergent policy approaches to addressing these crises.
Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher spending.
Get smart & reliable public policy insights right in your inbox.